CFRXQ — CONTRAFECT Share News
0.000.00%
Last trade - 00:00HealthcareHighly SpeculativeMicro Cap
NASDAQ TRADE HALT MARKET WIDE CIRCUIT BREAKER RESUMPTION AT 08:49 AM
ContraFect: Rises on breakthrough status for antibacterial
Brief: Contrafect Announces FDA's Breakthrough Therapy Designation To Exebacase
Brief: ContraFect Says Regained Compliance With Minimum Bid Price Requirement Set Forth In Nasdaq Listing Rule
Brief: Contrafect Announces One-For-Ten Reverse Stock Split
Brief: ContraFect Says First Patient Dosed In Pivotal Phase 3 DISRUPT Study of Exebacase
Brief: ContraFect Announces Initiation Of Pivotal Phase 3 Disrupt Study Of Exebacase As A Treatment For Staph Aureus Bacteremia, Including Right-Sided Endocarditis
Brief: ContraFect Announces First Gram-Negative Product Candidate CF-370
Brief: ContraFect Corp Prices Approximately $10 Mln Public Offering Of Common Stock
Brief: Pfizer Reports 8.7% Passive Stake In Contrafect Corp As Of Dec 12
U.S. RESEARCH ROUNDUP- Ameren, Potbelly, Vale
U.S. STOCKS ON THE MOVE-Peloton, Fitbit, Casey's, Tenneco
ContraFect rises after $10 mln stock offering, $3 mln private placement to Pfizer
Brief: ContraFect Prices About $10 Mln Public Offering Of Common Stock And Concurrent $3 Mln Private Placement Of Common Stock To Pfizer
U.S. STOCKS ON THE MOVE-Stitch Fix, Scynexis, Genworth Financial, Equillium
Brief: ContraFect Corp Announces Proposed Public Offering Of Common Stock
ContraFect jumps on equity raise plans; Pfizer to buy $3 mln worth of shares
Brief: Contrafect Reports Q3 Loss Per Share Of $0.07
U.S. STOCKS ON THE MOVE-United Natural Foods, Stitch Fix, Organovo, Acuity Brands